Cargando…
Reduced Food Intake is the Major Contributor to the Protective Effect of Rimonabant on Islet in Established Obesity-Associated Type 2 Diabetes
PURPOSE: Although the presence of cannabinoid type 1 (CB1) receptor in islets has been reported, the major contributor to the protective effect of rimonabant on islet morphology is unknown. We determined whether the protective effect of rimonabant on pancreatic islet morphology is valid in establish...
Autores principales: | Jin, Sang-Man, Oh, Bae Jun, Lee, Suel, Choi, Jung Mook, Yang, Soo Jin, Park, Sung Woo, Kim, Kwang-Won, Kim, Jae Hyeon, Park, Cheol-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Yonsei University College of Medicine
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3743202/ https://www.ncbi.nlm.nih.gov/pubmed/23918561 http://dx.doi.org/10.3349/ymj.2013.54.5.1127 |
Ejemplares similares
-
Rimonabant for treating tobacco dependence
por: Steinberg, Michael B, et al.
Publicado: (2007) -
Rimonabant: From RIO to Ban
por: Sam, Amir H., et al.
Publicado: (2011) -
Rimonabant, Gastrointestinal Motility and Obesity
por: Sun, Yan, et al.
Publicado: (2012) -
Rimonabant-induced depression in schizophrenia
por: Arasappa, Rashmi, et al.
Publicado: (2014) -
Rimonabant: the evidence for its use in the treatment of obesity and the metabolic syndrome
por: Waterlow, Mark, et al.
Publicado: (2007)